Integra LifeSciences to Present at Three Conferences in September
PLAINSBORO, N.J., Aug. 31, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it will present at the following conferences in the next month:
- At 9:45 AM ET on Friday, September 9, 2011, Mr. Brian Larkin, President, Global Spine & Orthobiologics and Head of Strategic Development of Integra, will present at the Stifel Nicolaus Healthcare Conference in Boston. A live webcast will be available for this conference and a replay will be accessible via a link on the investor relations page of our website: www.integralife.com.
- At 11:30 AM ET on Wednesday, September 14, 2011, Mr. Stuart Essig, Chief Executive Officer of Integra, will present at the Morgan Stanley Global Healthcare Conference in New York City. This presentation will not be webcast.
- At 3:45 PM ET on Wednesday, September 14, 2011, Mr. Essig will present at the C.L. King Best Ideas Conference in New York City. This presentation will not be webcast.
Integra LifeSciences, a world leader in medical devices, is dedicated to limiting uncertainty for surgeons, so they can concentrate on providing the best patient care. Integra offers innovative solutions in orthopedics, neurosurgery, spine, reconstructive and general surgery. For more information, please visit www.integralife.com
Statements made at the upcoming conferences may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties that could cause actual results to differ from predicted results. Forward-looking factors that may be discussed include, but are not limited to, future financial performance, new product development, governmental approvals, market potential and resulting sales as well as potential therapeutic applications, and additional acquisitions. These risks and uncertainties include market conditions and other factors beyond the Company's control and the economic, competitive, governmental, technological and other factors identified under the heading "Risk Factors" included in item IA of Integra's Annual Report on Form 10-K for the year ended December 31, 2010 and information contained in subsequent filings with the Securities and Exchange Commission could affect actual results. These forward-looking statements are made only as of the date thereof, and the Company undertakes no obligation to update or revise the forward-looking statements, whether as a result of new information, future events or otherwise.
CONTACT: Integra LifeSciences Holdings Corporation
John B. Henneman, III
Executive Vice President
and Chief Financial Officer
(609) 275-0500
jack.henneman@integralife.com
Investor Relations:
Angela Steinway
(609) 936-2268
angela.steinway@integralife.com